Developer docs
API playgroundTry for free, no card

Search company profiles

Coating Place Inc.

Full company profile

uuid000bs8a

Namestring
Coating Place Inc.
Legal namestring
Coating Place, Inc.
Company typeenum
Private
Founded yearint
1976
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersVerona, United States
HQ citystring
Verona
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical contract manufacturing, Wurster fluid bed coating, microencapsulation services, controlled release formulations, oral drug delivery
Industry2 codes
PRIMARYHLAGABAB
Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAGABAJ
Packaging, Labeling & Serialization (Clinical/Commercial) CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
NAICS code1 code
  • Paint, Coating, and Adhesive Manufacturing3255
SIC code1 code
  • Coating, Engraving & Allied Services3470
Product category
Pharmaceutical Contract Manufacturing (CDMO)
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1CDMO Contract Manufacturing Services
TypeProfessional Services
Description

Coating Place operates as a contract development and manufacturing organization providing fee-for-service work encompassing formulation development, technology transfer, process scale-up, and commercial manufacturing. Services are project-based with custom quotations depending on scope, batch size, and complexity. The company has supported the approval of more than 23 NDA/ANDA products.

coatingplace.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components7 values
Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales, Others
Pricing details1 tier
1Custom project-based pricing
ModelOtherBilling cadenceMulti-year contract
Notes

Services are quoted based on project scope, batch requirements, and specific coating/formulation needs. Net 30 payment terms with 1% monthly interest on overdue balances.

coatingplace.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 2 records shown
1Oradel®
Description

Proprietary platform of oral delivery coating techniques including multilayer coating, extended release, delayed release, enteric coating, and ion resin technology.

coatingplace.com
+1 more record
Core offering1 text field

Coating Place Inc. is a pharmaceutical contract development and manufacturing organization (CDMO) specializing in Wurster fluid bed microencapsulation technology. The company provides formulation development, process scale-up, technology transfer, validation, and commercial manufacturing of coated particles, granules, and dosage forms for pharmaceutical, nutraceutical, animal health, and industrial clients. Its branded offerings include the Oradel® oral delivery coating platform and the Encap™ line of microencapsulated products for industrial markets.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Supported approval of 23+ NDA/ANDA products
+2 more records
Product overview1 text field

Coating Place Inc. is a Contract Development and Manufacturing Organization (CDMO) specializing in proprietary Wurster fluid bed microencapsulation technology. The company's core offering is the Oradel® platform—a comprehensive oral delivery coating system comprising five distinct technologies (Multilayer Coating, Extended Release, Delayed Release, Enteric Coating, and Ion Resin Technology) that can be used individually or combined for customized drug release profiles. Complementing this is the Encap™ product line serving industrial oil and gas markets with encapsulated breakers for hydraulic fracturing. The company provides full-service CDMO capabilities including formulation development, tech transfer, process scale-up, process validation, particle engineering, analytical lab services, and dosage form manufacturing (capsules, tablets, pellets, bulk powder). Operations span pharmaceutical, nutraceutical, animal health, and specialty chemical end markets across two FDA-registered and DEA-licensed facilities totaling over 350,000 sq ft.

Product and service10 records
1Oradel® Oral Delivery Coating Platform
CategoryOral Drug Delivery Technology
2Encap™ Microencapsulated Product Line
CategoryIndustrial Microencapsulation Products
3Wurster Fluid Bed Coating Services
CategoryManufacturing Services
4Abuse-Deterrent Formulation Solutions
CategoryFormulation Development Services
Description

Development and manufacturing services for abuse-deterrent opioid and CNS drug formulations, leveraging Wurster coating and particle engineering to meet FDA guidance on tamper-resistant dosage forms.

5Technology Transfer Services
CategoryProcess Development Services
Description

End-to-end technology transfer of client-developed processes from R&D or pilot scales into Coating Place's commercial manufacturing facilities, including documentation, scale-up bridging, and regulatory support.

6Process Scale-Up Services
CategoryProcess Development Services
Description

Scale-up of Wurster coating and related processes from laboratory (0.01 kg) through pilot to commercial (800 kg) batch sizes using the company's FDA-recognized linear scalability methodology.

7Process Validation Services
CategoryProcess Development Services
Description

Process performance qualification (PPQ) and validation support for commercial Wurster coating and encapsulation batches, including execution of validation protocols and regulatory documentation.

8Particle Engineering Services
CategoryFormulation Development Services
Description

Custom particle engineering using high-shear granulation, fluid bed granulation, extrusion, and spheronization to engineer particle size, density, morphology, and release characteristics for client APIs.

9Analytical Laboratory Services
CategoryQuality / Analytical Services
Description

In-house analytical testing supporting coating development and GMP release, including assay, content uniformity, dissolution testing, particle size analysis, and stability support.

10Dosage Form Manufacturing Services
CategoryCommercial Manufacturing
Description

Finished dosage form manufacturing of coated oral solid dose products, including DEA-licensed handling of Schedule I-V controlled substances, for pharmaceutical commercial supply.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Recent move11 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Pharmaceutical CDMO with particle engineering, formulation development, and oral dosage capabilities. Comparable in offering development and GMP manufacturing services to pharma sponsors.

2Glatt Pharmaceutical Services
TypeDirect peer
Description

Operates fluid bed and Wurster coating technology for pharmaceutical applications, directly competing with Coating Place's core Wurster process technology and oral solid dose CDMO offering.

TypeEmerging player
Description

CDMO specializing in particle engineering, spray drying, and oral dosage form development. Overlaps with Coating Place's particle engineering, scale-up, and controlled-release capabilities for pharma sponsors.

TypeDirect peer
Description

CDMO specializing in oral solid dosage forms including taste masking, controlled release, and complex formulation. Directly comparable to Coating Place's Oradel® platform and pharma customer base.

TypeBroad incumbent
Description

Large-scale global CDMO with overlapping oral solid dose, softgel, and controlled-release capabilities. A broad incumbent in the same pharma outsourcing space that Coating Place serves.

TypeBroad incumbent
Description

Global CDMO with pharma oral solid dose capabilities alongside biologics. A broad incumbent that competes for outsourced pharmaceutical manufacturing contracts globally.

TypeBroad incumbent
Description

European-headquartered pharmaceutical CDMO with strong oral solid dose capabilities. A broad incumbent that competes for similar oral solid dose CDMO work, though geographically concentrated in Europe.

TypeBroad incumbent
Description

Global pharma services/CDMO platform under Thermo Fisher with extensive oral solid dose, API, and biologics manufacturing. Competes for the same CDMO contracts as Coating Place at significantly larger scale.

TypeBroad incumbent
Description

Small-molecule API and finished dosage CDMO serving global pharma. A broad incumbent competing for similar pharmaceutical contract manufacturing work.

TypeEmerging player
Description

Specialty CDMO focused on complex and poorly soluble formulations including nanoemulsions, amorphous dispersions, and oral controlled-release dosage forms. Comparable emerging player targeting similar pharma outsourcing customers.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature10 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles8 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance9 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Coating Place Inc.

Pharmaceutical Contract Manufacturing (CDMO)coatingplace.com

Coating Place Inc. firmographics

Firmographics
Name
Coating Place Inc.
Legal name
Coating Place, Inc.
Website
https://coatingplace.com
Company type
Private
Founded year
1976
Operating status
Operating
Headcount range
101–250 employees
Ownership category
akta.pro rank

Coating Place Inc. industry classification

Industry
Product category
Pharmaceutical Contract Manufacturing (CDMO)
NAICS
Paint, Coating, and Adhesive Manufacturing (3255)
SIC
Coating, Engraving & Allied Services (3470)
akta.pro industry
PRIMARYHLAGABAB
Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAGABAJ
Packaging, Labeling & Serialization (Clinical/Commercial) CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)

Keywords

  • Pharmaceutical contract manufacturing
  • Wurster fluid bed coating
  • Microencapsulation services
  • Controlled release formulations
  • Oral drug delivery

Where Coating Place Inc. is headquartered

Location

Headquarters

HQ city
Verona
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Coating Place Inc. business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales, Others

Revenue model

  1. CDMO Contract Manufacturing Services: Coating Place operates as a contract development and manufacturing organization providing fee-for-service work encompassing formulation development, technology transfer, process scale-up, and commercial manufacturing. Services are project-based with custom quotations depending on scope, batch size, and complexity. The company has supported the approval of more than 23 NDA/ANDA products.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractCustom project-based pricing

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Coating Place Inc. product offering

Product offering

Core offering

Coating Place Inc. is a pharmaceutical contract development and manufacturing organization (CDMO) specializing in Wurster fluid bed microencapsulation technology. The company provides formulation development, process scale-up, technology transfer, validation, and commercial manufacturing of coated particles, granules, and dosage forms for pharmaceutical, nutraceutical, animal health, and industrial clients. Its branded offerings include the Oradel® oral delivery coating platform and the Encap™ line of microencapsulated products for industrial markets.

Product overview

Coating Place Inc. is a Contract Development and Manufacturing Organization (CDMO) specializing in proprietary Wurster fluid bed microencapsulation technology. The company's core offering is the Oradel® platform—a comprehensive oral delivery coating system comprising five distinct technologies (Multilayer Coating, Extended Release, Delayed Release, Enteric Coating, and Ion Resin Technology) that can be used individually or combined for customized drug release profiles. Complementing this is the Encap™ product line serving industrial oil and gas markets with encapsulated breakers for hydraulic fracturing. The company provides full-service CDMO capabilities including formulation development, tech transfer, process scale-up, process validation, particle engineering, analytical lab services, and dosage form manufacturing (capsules, tablets, pellets, bulk powder). Operations span pharmaceutical, nutraceutical, animal health, and specialty chemical end markets across two FDA-registered and DEA-licensed facilities totaling over 350,000 sq ft.

Differentiator

Problem solved

Functional benefit

Brands

  • Oradel®: Proprietary platform of oral delivery coating techniques including multilayer coating, extended release, delayed release, enteric coating, and ion resin technology.
  • Encap™

Products and services

  • Oradel® Oral Delivery Coating Platform
  • Encap™ Microencapsulated Product Line
  • Wurster Fluid Bed Coating Services
  • Abuse-Deterrent Formulation Solutions Development and manufacturing services for abuse-deterrent opioid and CNS drug formulations, leveraging Wurster coating and particle engineering to meet FDA guidance on tamper-resistant dosage forms.
  • Technology Transfer Services End-to-end technology transfer of client-developed processes from R&D or pilot scales into Coating Place's commercial manufacturing facilities, including documentation, scale-up bridging, and regulatory support.
  • Process Scale-Up Services Scale-up of Wurster coating and related processes from laboratory (0.01 kg) through pilot to commercial (800 kg) batch sizes using the company's FDA-recognized linear scalability methodology.
  • Process Validation Services Process performance qualification (PPQ) and validation support for commercial Wurster coating and encapsulation batches, including execution of validation protocols and regulatory documentation.
  • Particle Engineering Services Custom particle engineering using high-shear granulation, fluid bed granulation, extrusion, and spheronization to engineer particle size, density, morphology, and release characteristics for client APIs.
  • Analytical Laboratory Services In-house analytical testing supporting coating development and GMP release, including assay, content uniformity, dissolution testing, particle size analysis, and stability support.
  • Dosage Form Manufacturing Services Finished dosage form manufacturing of coated oral solid dose products, including DEA-licensed handling of Schedule I-V controlled substances, for pharmaceutical commercial supply.

Quantifiable outcome

  • Supported approval of 23+ NDA/ANDA products
  • +2 more outcomes

Companies that use Coating Place Inc.

Customer profile

Segments4 records

Ideal customer profiles4 records

Coating Place Inc. technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature10 records

Coating Place Inc. partnerships and signals

Strategic signal

Scale indicators6 records

Recent moves11 records

Expansion highlights5 records

Coating Place Inc. competitors and assessment

Company assessment

Broad incumbents

  • Eurofins CDMO (formerly Bend Research): Pharmaceutical CDMO with particle engineering, formulation development, and oral dosage capabilities. Comparable in offering development and GMP manufacturing services to pharma sponsors.
  • Catalent Pharma Solutions: Large-scale global CDMO with overlapping oral solid dose, softgel, and controlled-release capabilities. A broad incumbent in the same pharma outsourcing space that Coating Place serves.
  • Lonza Group: Global CDMO with pharma oral solid dose capabilities alongside biologics. A broad incumbent that competes for outsourced pharmaceutical manufacturing contracts globally.
  • Aenova Group: European-headquartered pharmaceutical CDMO with strong oral solid dose capabilities. A broad incumbent that competes for similar oral solid dose CDMO work, though geographically concentrated in Europe.
  • Patheon (Thermo Fisher Scientific): Global pharma services/CDMO platform under Thermo Fisher with extensive oral solid dose, API, and biologics manufacturing. Competes for the same CDMO contracts as Coating Place at significantly larger scale.
  • Cambrex: Small-molecule API and finished dosage CDMO serving global pharma. A broad incumbent competing for similar pharmaceutical contract manufacturing work.

Direct peers

  • Glatt Pharmaceutical Services: Operates fluid bed and Wurster coating technology for pharmaceutical applications, directly competing with Coating Place's core Wurster process technology and oral solid dose CDMO offering.
  • Adare Pharma Solutions: CDMO specializing in oral solid dosage forms including taste masking, controlled release, and complex formulation. Directly comparable to Coating Place's Oradel® platform and pharma customer base.

Emerging players

  • Hovione: CDMO specializing in particle engineering, spray drying, and oral dosage form development. Overlaps with Coating Place's particle engineering, scale-up, and controlled-release capabilities for pharma sponsors.
  • Ascendia Pharmaceuticals: Specialty CDMO focused on complex and poorly soluble formulations including nanoemulsions, amorphous dispersions, and oral controlled-release dosage forms. Comparable emerging player targeting similar pharma outsourcing customers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Coating Place Inc. social profiles

Digital presence

Coating Place Inc. compliance and trust

Trust signal

Compliance9 records

Coating Place Inc. financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Coating Place Inc. leadership team

Management profile

Number of profiles

Profiles8 records

Coating Place Inc. funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Coating Place Inc. M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Coating Place Inc.

What does Coating Place Inc. do?

Coating Place Inc. is a pharmaceutical contract development and manufacturing organization (CDMO) specializing in Wurster fluid bed microencapsulation technology. The company provides formulation development, process scale-up, technology transfer, validation, and commercial manufacturing of coated particles, granules, and dosage forms for pharmaceutical, nutraceutical, animal health, and industrial clients. Its branded offerings include the Oradel® oral delivery coating platform and the Encap™ line of microencapsulated products for industrial markets.

Is Coating Place Inc. a public or private company?

Coating Place Inc. is a private company. It is classified as family owned and is currently operating.

When was Coating Place Inc. founded?

Coating Place Inc. was founded in 1976. It employs 101 to 250 people.

Where is Coating Place Inc. based?

Coating Place Inc. is headquartered in Verona, United States, in the North America region.

How does Coating Place Inc. make money?

One revenue line is on record: CDMO Contract Manufacturing Services.

Who are Coating Place Inc.'s main competitors?

Broad incumbents on record are Eurofins CDMO (formerly Bend Research), Catalent Pharma Solutions, Lonza Group, Aenova Group, Patheon (Thermo Fisher Scientific) and Cambrex. Direct peers are Glatt Pharmaceutical Services and Adare Pharma Solutions. Emerging players are Hovione and Ascendia Pharmaceuticals.

Does Coating Place Inc. have an API?

No public API is recorded for Coating Place Inc..

What industry is Coating Place Inc. in?

Coating Place Inc.'s product category is Pharmaceutical Contract Manufacturing (CDMO). Its primary akta.pro industry code is HLAGABAB, Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO, with a secondary code of HLAGABAJ, Packaging, Labeling & Serialization (Clinical/Commercial) CDMO. Its NAICS code is 3255 and its SIC code is 3470.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals